Drug combinations for malaria: time to ACT?
- 1 January 2004
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 363 (9402) , 3-4
- https://doi.org/10.1016/s0140-6736(03)15230-0
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policyTropical Medicine & International Health, 2003
- Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trialThe Lancet, 2002
- Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective studyThe Lancet, 2000
- Treatment of Malaria in Vietnam with Oral ArtemisininThe American Journal of Tropical Medicine and Hygiene, 1993
- Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu onPlasmodium falciparumZeitschrift Fur Parasitenkunde-Parasitology Research, 1990
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985